| HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation N Chomont, M El-Far, P Ancuta, L Trautmann, FA Procopio, ... Nature medicine 15 (8), 893-900, 2009 | 1980 | 2009 |
| Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction L Trautmann, L Janbazian, N Chomont, EA Said, S Gimmig, B Bessette, ... Nature medicine 12 (10), 1198-1202, 2006 | 1945 | 2006 |
| Towards an HIV cure: a global scientific strategy Nature reviews Immunology 12 (8), 607-614, 2012 | 612 | 2012 |
| The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo OS Søgaard, ME Graversen, S Leth, R Olesen, CR Brinkmann, SK Nissen, ... PLoS pathogens 11 (9), e1005142, 2015 | 578 | 2015 |
| Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ... PLoS pathogens 10 (11), e1004473, 2014 | 568 | 2014 |
| International AIDS Society global scientific strategy: towards an HIV cure 2016 SG Deeks, SR Lewin, AL Ross, J Ananworanich, M Benkirane, P Cannon, ... Nature medicine 22 (8), 839-850, 2016 | 492 | 2016 |
| Immune activation and HIV persistence: implications for curative approaches to HIV infection NR Klatt, N Chomont, DC Douek, SG Deeks Immunological reviews 254 (1), 326-342, 2013 | 475 | 2013 |
| Virologic effects of broadly neutralizing antibody VRC01 administration during chronic HIV-1 infection RM Lynch, E Boritz, EE Coates, A DeZure, P Madden, P Costner, ... Science translational medicine 7 (319), 319ra206-319ra206, 2015 | 471 | 2015 |
| CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART R Fromentin, W Bakeman, MB Lawani, G Khoury, W Hartogensis, ... PLoS pathogens 12 (7), e1005761, 2016 | 460 | 2016 |
| Peripheral blood CCR4+ CCR6+ and CXCR3+ CCR6+ CD4+ T cells are highly permissive to HIV-1 infection A Gosselin, P Monteiro, N Chomont, F Diaz-Griffero, EA Said, S Fonseca, ... The Journal of Immunology 184 (3), 1604-1616, 2010 | 384 | 2010 |
| Identification of genetically intact HIV-1 proviruses in specific CD4+ T cells from effectively treated participants B Hiener, BA Horsburgh, JS Eden, K Barton, TE Schlub, E Lee, ... Cell reports 21 (3), 813-822, 2017 | 380 | 2017 |
| Impact of multi-targeted antiretroviral treatment on gut T cell depletion and HIV reservoir seeding during acute HIV infection J Ananworanich, A Schuetz, C Vandergeeten, I Sereti, M De Souza, ... PloS one 7 (3), e33948, 2012 | 353 | 2012 |
| HIV persistence and the prospect of long-term drug-free remissions for HIV-infected individuals D Trono, C Van Lint, C Rouzioux, E Verdin, F Barré-Sinoussi, TW Chun, ... science 329 (5988), 174-180, 2010 | 347 | 2010 |
| Rapid HIV RNA rebound after antiretroviral treatment interruption in persons durably suppressed in Fiebig I acute HIV infection DJ Colby, L Trautmann, S Pinyakorn, L Leyre, A Pagliuzza, E Kroon, ... Nature medicine 24 (7), 923-926, 2018 | 327 | 2018 |
| A novel assay to measure the magnitude of the inducible viral reservoir in HIV-infected individuals FA Procopio, R Fromentin, DA Kulpa, JH Brehm, AG Bebin, MC Strain, ... EBioMedicine 2 (8), 874-883, 2015 | 307 | 2015 |
| Interleukin-7 promotes HIV persistence during antiretroviral therapy C Vandergeeten, R Fromentin, S DaFonseca, MB Lawani, I Sereti, ... Blood, The Journal of the American Society of Hematology 121 (21), 4321-4329, 2013 | 274 | 2013 |
| Editor's choice: persistent, albeit reduced, chronic inflammation in persons starting antiretroviral therapy in acute HIV infection I Sereti, SJ Krebs, N Phanuphak, JL Fletcher, B Slike, S Pinyakorn, ... Clinical infectious diseases: an official publication of the Infectious …, 2017 | 269 | 2017 |
| HIV DNA set point is rapidly established in acute HIV infection and dramatically reduced by early ART J Ananworanich, N Chomont, LA Eller, E Kroon, S Tovanabutra, M Bose, ... EBioMedicine 11, 68-72, 2016 | 249 | 2016 |
| HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study TJ Henrich, H Hatano, O Bacon, LE Hogan, R Rutishauser, A Hill, ... PLoS medicine 14 (11), e1002417, 2017 | 241 | 2017 |
| Cross-clade ultrasensitive PCR-based assays to measure HIV persistence in large-cohort studies C Vandergeeten, R Fromentin, E Merlini, MB Lawani, S DaFonseca, ... Journal of virology 88 (21), 12385-12396, 2014 | 230 | 2014 |
Jean-Pierre RoutyMcGill University Health CentreVerified email at mcgill.ca
